Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients - Drugs.com MedNews
Links shared publicly online about this topic.
- 1,111total visits
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients - Drugs.com MedNews
- One-Year Phase II Data Presented at the 2010 ACTRIMS Meeting Sanofi-aventis (EURONEXT SAN and NYSE SNY) reported today new one-year data from a Phase II study
View full resource at drugs.com
Tags: Multiple Sclerosis, Sanofi-Aventis
Most Recently Shared on June 7, 2010 at 6:50 pm By:
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients: PARIS,... http://bit.ly/c1x7WK
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients - News Press Release | PharmiWeb.com
pharmiweb.com — “- One-Year Phase II Data Presented at the 2010 ACTRIMS MeetingPR NewswirePARIS, June 5, 2010PARIS, June 5, 2010 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) reported today new one-year data from a Phase II study with teriflunomide, a” View full resource at pharmiweb.com
Most Recently Shared on June 7, 2010 at 12:52 pm By:
Press Release: PARIS, June 5, 2010 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) reported today new... http://bit.ly/apPTtX
Advertisement
